Vol 30 No 7

Discontinuing Medications: When, Why, and How-to

July 19, 2013

Most often, psychiatric medications are discontinued unilaterally by the patient, without the psychiatrist’s input or consent. Setting the stage early with a discussion about medication discontinuation is time well spent. More in this CME.

Characteristics of Sleep Disorders in Women

July 19, 2013

This brief review addresses what is currently known about sleep problems in women. The main focus is on sleep issues that are particularly relevant to reproductive stages in a woman’s life cycle and therefore potentially linked to reproductive and/or hormonal factors.

Olanzapine/Fluoxetine Combination Affirmed for Bipolar Depression

July 17, 2013

A recent meta-analysis supports evidence of the effectiveness of the fixed olanzapine/fluoxetine combination (Symbyax) in treating the depressive phase of bipolar disorder. Response was ranked higher, but with no more adverse effects, than with treatment with olanzapine alone.

Obesity in Patients With Psychiatric Conditions

July 11, 2013

Obesity is one of the most common physical health problems in individuals with psychiatric conditions and contributes to excess medical morbidity and mortality. Several classes of psychotropic medications, particularly atypical antipsychotics, cause weight gain. While these issues pose challenges to optimal health, the good news is that there are solutions and emerging strategies.

A Eulogy for Psychiatry's Abraham: A Model of Ethics, Forensics, Advocacy, and Humanitarianism

June 07, 2013

At the recent annual APA meeting, Dr Abraham Halpern was posthumously honored for the second annual Humanitarian Award by the American Association for Social Psychiatry. He was honored for his contributions to ethics, forensics, and advocacy of social issues.